AngioDynamics, Inc. last reported quarterly results on Oct 8, 2026, for Q1 FY2027 (the quarter ended Aug 31, 2026): revenue of $80.9 million (+6.9% year over year) and diluted EPS of -$0.17. It usually reports 33–44 days after a quarter ends. Based on that pattern, the next release is estimated for around Jan 5, 2027.
Results for Q2 FY2027, the quarter ending around Nov 30, 2026. Expected on a Tuesday. Based on last year's release for the same quarter on Jan 6, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 33–44 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Oct 8, 2026
38 days after quarter end
|
Q1 FY2027
ended Aug 31, 2026
|
81
+6.9%
|
-7
+34.9%
|
-0.17
+34.6%
|
|
Jul 14, 2026
44 days after quarter end
|
Q4 FY2026
ended May 31, 2026
|
87
+8.0%
|
-11
-88.5%
|
-0.27
-85.3%
|
|
Apr 2, 2026
33 days after quarter end
|
Q3 FY2026
ended Feb 28, 2026
|
78
+8.9%
|
-8
-83.4%
|
-0.19
-72.7%
|
|
Jan 6, 2026
37 days after quarter end
|
Q2 FY2026
ended Nov 30, 2025
|
79
+9.0%
|
-6
+40.9%
|
-0.15
+42.3%
|
|
Oct 2, 2025
32 days after quarter end
|
Q1 FY2026
ended Aug 31, 2025
|
76
+12.2%
|
-11
+14.8%
|
-0.26
+16.1%
|
|
Jul 15, 2025
45 days after quarter end
|
Q4 FY2025
ended May 31, 2025
|
80
+12.9%
|
-6
+55.0%
|
-0.15
+55.6%
|
|
Apr 2, 2025
33 days after quarter end
|
Q3 FY2025
ended Feb 28, 2025
|
72
-4.2%
|
-4
+97.7%
|
-0.11
+97.6%
|
|
Jan 8, 2025
39 days after quarter end
|
Q2 FY2025
ended Nov 30, 2024
|
73
-7.9%
|
-11
+63.0%
|
-0.26
+63.9%
|
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- ANGO (Nasdaq)
- Fiscal year ends
- May 31
- Incorporated in
- DE
- Headquarters
- Latham, NY
- SEC filer status
- Accelerated filer
- SEC CIK
- 1275187
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.